enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Pegunigalsidase alfa - Wikipedia

    en.wikipedia.org/wiki/Pegunigalsidase_alfa

    Pegunigalsidase alfa, sold under the brand name Elfabrio, is an enzyme replacement therapy for the treatment of Fabry disease. [2] [4] It is a recombinant human α-galactosidase-A. [4] It is a hydrolytic lysosomal neutral glycosphingolipid-specific enzyme. [2] The most common side effects are infusion-related reactions, hypersensitivity and ...

  3. Fabry disease - Wikipedia

    en.wikipedia.org/wiki/Fabry_disease

    A person who inherits this gene does not have enough of a functioning enzyme known as alpha-galactosidase A. The lack of alpha-galactosidase leads to Fabry disease. A deficiency of alpha galactosidase A (a-GAL A, encoded by GLA) due to mutation causes a glycolipid known as globotriaosylceramide (abbreviated as Gb3, GL-3, or ceramide trihexoside ...

  4. α-Galactosidase - Wikipedia

    en.wikipedia.org/wiki/Α-Galactosidase

    α-Galactosidase ( EC 3.2.1.22, α-GAL, α-GAL A; systematic name α-D-galactoside galactohydrolase) is a glycoside hydrolase enzyme that catalyses the following reaction: [1] Hydrolysis of terminal, non-reducing α- D -galactose residues in α- D -galactosides, including galactose oligosaccharides, galactomannans and galactolipids

  5. Globotriaosylceramide - Wikipedia

    en.wikipedia.org/wiki/Globotriaosylceramide

    Defects in the enzyme alpha-galactosidase lead to the buildup of globotriaosylceramide, causing Fabry's disease. [3] The pharmaceutical drug migalastat enhances the function of alpha-galactosidase and is used to treat Fabry's.

  6. GLA (gene) - Wikipedia

    en.wikipedia.org/wiki/GLA_(gene)

    Two recombinant enzyme replacement therapies are available to functionally compensate for α-galactosidase deficiency. Agalsidase α and β are both recombinant forms of the human α-galactosidase A enzyme and both have the same amino acid sequence as the native enzyme. Agalsidase α and β differ in the structures of their oligosaccharide side ...

  7. Alglucosidase alfa - Wikipedia

    en.wikipedia.org/wiki/Alglucosidase_alfa

    Alglucosidase alfa, sold under the brand name Myozyme among others, is an enzyme replacement therapy (ERT) orphan drug for treatment of Pompe disease (Glycogen storage disease type II), a rare lysosomal storage disorder (LSD). [6] Chemically, the drug is an analog of the enzyme that is deficient in patients affected by Pompe disease, alpha ...

  8. Vet-Approved Home Treatment for Senior Dogs with Arthritis - AOL

    www.aol.com/vet-approved-home-treatment-senior...

    This therapy works by returning the balance to a dog's yin and yang, according to the Chinese, or by pressing the muscles and improving circulation, similar to massage. This will not cure ...

  9. Cushing's syndrome (veterinary) - Wikipedia

    en.wikipedia.org/wiki/Cushing's_syndrome...

    Disadvantages of mitotane as a treatment include the side effects and the requirement for blood test monitoring. Issues can arise when too much of the adrenal cortex becomes eroded. Approximately 30% of dogs will experience a reaction in response to treatment with mitotane; prednisone may be used as an antidote. In the event of a reaction ...